EPEG (pegylated recombinant erythropoietin) / Cadila, Prolong Pharma 
Welcome,         Profile    Billing    Logout  
 2 Diseases   1 Trial   1 Trial   2 News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
EPEG (pegylated recombinant erythropoietin) / Cadila, Prolong Pharma
ACTRN12613000374763: A Phase 1 Single Blind, Randomized, Single-Dose, Safety, Tolerability, Pharmacodynamic, and Pharmacokinetic Study of ZY7318 (pegylated recombinant human erythropoietin) in Healthy Volunteers

Recruiting
1
32
 
Prolong Pharmaceuticals, LLC, Prolong Pharmaceuticals, LLC
Healthy volunteers study and investigational product would be targeted for secondary anemia due to renal cause.
 
 

Download Options